Fairfield, Bush & Co’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.07M | Sell |
7,762
-306
| -4% | -$82.9K | 1.15% | 31 |
|
|
2025
Q4 | $2.02M | Sell |
8,068
-1,744
| -18% | -$463K | 1.07% | 29 |
|
|
2025
Q3 | $2.82M | Sell |
9,812
-42
| -0.4% | -$11.3K | 1.45% | 20 |
|
|
2025
Q2 | $2.59M | Sell |
9,854
-489
| -5% | -$119K | 1.46% | 19 |
|
|
2025
Q1 | $2.41M | Sell |
10,343
-1,025
| -9% | -$249K | 1.53% | 17 |
|
|
2024
Q4 | $2.61M | Buy |
11,368
+409
| +4% | +$93.8K | 1.53% | 16 |
|
|
2024
Q3 | $2.45M | Sell |
10,959
-1,810
| -14% | -$398K | 1.46% | 18 |
|
|
2024
Q2 | $2.6M | Sell |
12,769
-75
| -0.6% | -$15.3K | 1.56% | 17 |
|
|
2024
Q1 | $2.81M | Sell |
12,844
-221
| -2% | -$48.7K | 1.66% | 15 |
|
|
2023
Q4 | $2.97M | Sell |
13,065
-1,957
| -13% | -$411K | 1.74% | 14 |
|
|
2023
Q3 | $3.02M | Sell |
15,022
-4,090
| -21% | -$863K | 1.97% | 12 |
|
|
2023
Q2 | $3.96M | Sell |
19,112
-43
| -0.2% | -$8.34K | 1.09% | 21 |
|
|
2023
Q1 | $3.78M | Buy |
19,155
+1,387
| +8% | +$285K | 1.33% | 21 |
|
|
2022
Q4 | $3.59M | Sell |
17,768
-495
| -3% | -$96.7K | 2.37% | 12 |
|
|
2022
Q3 | $3.21M | Sell |
18,263
-2,308
| -11% | -$473K | 2.27% | 13 |
|
|
2022
Q2 | $4.14M | Sell |
20,571
-3,073
| -13% | -$655K | 2.44% | 10 |
|
|
2022
Q1 | $5.36M | Buy |
23,644
+5
| +0% | +$1.18K | 2.69% | 9 |
|
|
2021
Q4 | $6.38M | Sell |
23,639
-2,865
| -11% | -$709K | 3.07% | 8 |
|
|
2021
Q3 | $6.41M | Sell |
26,504
-6,374
| -19% | -$1.61M | 2.08% | 11 |
|
|
2021
Q2 | $7.79M | Sell |
32,878
-1,594
| -5% | -$363K | 2.12% | 10 |
|
|
2021
Q1 | $7.55M | Buy |
34,472
+79
| +0.2% | +$15.9K | 2.16% | 10 |
|
|
2020
Q4 | $6.01M | Hold |
34,393
| – | – | 1.75% | 12 |
|
|
2020
Q3 | $5.56M | Sell |
34,393
-116
| -0.3% | -$18.4K | 1.78% | 13 |
|
|
2020
Q2 | $4.92M | Sell |
34,509
-47
| -0.1% | -$6.5K | 1.76% | 14 |
|
|
2020
Q1 | $3.75M | Sell |
34,556
-457
| -1% | -$65.8K | 1.56% | 15 |
|
|
2019
Q4 | $5.09M | Sell |
35,013
-483
| -1% | -$69.7K | 1.87% | 14 |
|
|
2019
Q3 | $5.12M | Sell |
35,496
-1,950
| -5% | -$285K | 1.77% | 15 |
|
|
2019
Q2 | $5.56M | Sell |
37,446
-6,024
| -14% | -$841K | 1.9% | 16 |
|
|
2019
Q1 | $5.71M | Sell |
43,470
-828
| -2% | -$102K | 1.9% | 16 |
|
|
2018
Q4 | $4.81M | Sell |
44,298
-326
| -0.7% | -$43.7K | 1.65% | 20 |
|
|
2018
Q3 | $6.66M | Sell |
44,624
-6,139
| -12% | -$934K | 1.87% | 14 |
|
|
2018
Q2 | $7.83M | Sell |
50,763
-4,086
| -7% | -$617K | 2.3% | 11 |
|
|
2018
Q1 | $7.62M | Sell |
54,849
-8,873
| -14% | -$1.3M | 2.21% | 12 |
|
|
2017
Q4 | $8.73M | Buy |
63,722
+4,807
| +8% | +$635K | 2.41% | 11 |
|
|
2017
Q3 | $7.64M | Sell |
58,915
-116
| -0.2% | -$15.5K | 2.39% | 12 |
|
|
2017
Q2 | $7.82M | Sell |
59,031
-524
| -0.9% | -$64.2K | 2.51% | 12 |
|
|
2017
Q1 | $7.34M | Sell |
59,555
-780
| -1% | -$92.4K | 2.29% | 15 |
|
|
2016
Q4 | $6.65M | Sell |
60,335
-58
| -0.1% | -$6.44K | 2.16% | 16 |
|
|
2016
Q3 | $7.13M | Sell |
60,393
-565
| -0.9% | -$66.6K | 2.31% | 13 |
|
|
2016
Q2 | $6.82M | Sell |
60,958
-1,641
| -3% | -$177K | 2.37% | 13 |
|
|
2016
Q1 | $6.3M | Buy |
62,599
+33,745
| +117% | +$3.24M | 2.25% | 16 |
|
|
2015
Q4 | $3.06M | Hold |
28,854
| – | – | 1.07% | 34 |
|
|
2015
Q3 | $2.69M | Buy |
28,854
+156
| +0.5% | +$16.1K | 1.18% | 29 |
|
|
2015
Q2 | $2.99M | Sell |
28,698
-600
| -2% | -$62.5K | 0.9% | 38 |
|
|
2015
Q1 | $3.17M | Buy |
29,298
+29
| +0.1% | +$2.98K | 0.93% | 39 |
|
|
2014
Q4 | $2.71M | Sell |
29,269
-186
| -0.6% | -$16.4K | 0.78% | 42 |
|
|
2014
Q3 | $2.58M | Sell |
29,455
-780
| -3% | -$70.5K | 0.74% | 43 |
|
|
2014
Q2 | $2.66M | Sell |
30,235
-303
| -1% | -$26.2K | 0.78% | 43 |
|
|
2014
Q1 | $2.58M | Sell |
30,538
-11
| -0% | -$877 | 1.21% | 32 |
|
|
2013
Q4 | $2.4M | Sell |
30,549
-4,016
| -12% | -$343K | 1.07% | 34 |
|
|
2013
Q3 | $2.94M | Buy |
+34,565
| New | +$2.91M | 0.89% | 40 |
|
Other funds holding LH
VCM
VPM
Fairfield, Bush & Co's LH Position: Q1 2026 in Review
Fairfield, Bush & Co reduced its Labcorp (LH) stake by 3.8% in Q1 2026, selling an estimated $82.9K and leaving 7,762 shares worth $2.07M. The position accounts for 1.15% of the portfolio, ranked #31.
Fairfield, Bush & Co first reported a position in LH in Q3 2013 and has held it in 51 quarters since. The position peaked at $8.73M in Q4 2017. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Fairfield, Bush & Co held 7,762 shares of Labcorp worth $2.07M as of Q1 2026.
- Fairfield, Bush & Co sold 306 Labcorp shares in Q1 2026, an estimated $82.9K.
- Labcorp made up 1.15% of Fairfield, Bush & Co's portfolio in Q1 2026, its #31 holding.
- Fairfield, Bush & Co first reported a position in Labcorp in Q3 2013 and has held it in 51 quarters since.
- Fairfield, Bush & Co's Labcorp position peaked at $8.73M in Q4 2017.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.